Anthropic quietly enters the drug discovery race with a new biology lab
- Anthropic has quietly set up a physical biology lab in the San Francisco Bay Area to work on life sciences.
- The AI firm wants Claude to help automate lab experiments using robotic systems, with humans overseeing the work.
- Anthropic is targeting rare and neglected diseases, including conditions it believes have been difficult to treat.
- The company has acquired Coefficient Bio, launched Claude Science and plans preclinical drug work, but isn’t running clinical trials yet.
Source: reuters.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
